Management of attention deficit hyperactivity disorder: A parental perspective

Journal of Paediatrics and Child Health

Volumn 41, Issue 12, 2005, Pages 625-630

  Concannon, P E ^a,b   Tang, Y P ^a  

^a Child and Family Health Service   (Australia)

^b Child and Adol Mental Hlth Serv   (Australia)

Author keywords

Attention deficit hyperactivity disorder; Complementary and alternative medicine; Perceptions; Practice guidelines; Satisfaction

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; FATTY ACID; METHYLPHENIDATE; VITAMIN;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; BEHAVIOR THERAPY; CHIROPRACTIC; CONTROLLED STUDY; DIET SUPPLEMENTATION; HEALTH CARE QUALITY; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; OCCUPATIONAL THERAPY; OPTOMETRY; OSTEOPATHIC MEDICINE; PARENT; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SATISFACTION; SCHOOL CHILD; SPECIAL EDUCATION; SPEECH THERAPY; ATTITUDE TO HEALTH; CHILD; COMPARATIVE STUDY; FEMALE; MALE; PATIENT SATISFACTION; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL; UTILIZATION REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; AUSTRALIA; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMPLEMENTARY THERAPIES; DEXTROAMPHETAMINE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PARENTS; PATIENT SATISFACTION; PERSONAL SATISFACTION; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCHOOLS;

EID: 33644854758     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2005.00771.x     Document Type: Article

References (38)

1. Jureidini J. Does the international consensus statement on ADHD leave room for health scepticism? Eur. J. Child Adolesc. Psychiatry 2002 11 (5 95 9.
2. Jensen PS. Are stimulants overprescribed? Treatment of ADHD in 4 US communities. J. Am. Acad. Child Adolesc. Psychiatry 1999 38 : 797 804.
3. Sawyer M, Rey J, Graeter B et al. Use of medication by young people with attention deficit/hyperactivity disorder. Med. J. Aust. 2002 177 (1 21 5.
4. Global ADHD Working Group. Global consensus on ADHD/HKD. Eur. J. Child Adolesc. Psychiatry 2005 14 : 127 37.
5. National Health and Medical Research Council. Attention Deficit Hyperactivity Disorder. Australian Government Publishing Service, Canberra 1996.
6. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of ADHD. J. Am. Acad. Child Adolesc. Psychiatry 1997 36 : 85s 121s.
7. Committee on quality improvement and subcommittee on ADHD, clinical practice guidelines: Diagnosis and evaluation of the child with ADHD. Pediatrics 2000 105 : 1158 70.
8. Wasserman RC, Kelleher K, Kelly J et al. Identification of attentional and hyperactivity problems in primary care: A report from pediatric research in office setting and the ambulatory sentinel practice network. Pediatrics 1999 103 (3 e661.
9. Rushton JL, Fant K, Clark S. Use of practice guidelines in the primary care of children with ADHD. Pediatrics 2000 114 (1 e23 8.
10. Hazell P, McDowell M, Walton J. Management of children prescribed psychostimulant medication for attention deficit hyperactivity disorder in the Hunter region of NSW. Med. J. Aust. 1996 165 : 477 80.
11. Kemper KJ. Complementary and alternative medicine for children: Does it work? Arch. Dis. Child. 2001 84 (1 6 9.
12. South M, Lim A. Use of complementary and alternative medicine in children: Too important to ignore. J. Paediatr. Child Health 2003 39 : 573 4.
13. Stubberfield TG, Wray JA, Parry TS. Utilisation of alternative therapies in attention-deficit hyperactivity disorder. J. Paediatr. Child Health 1999 35 : 450 53.
14. Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J. Paediatr. Child Health 2005 41 : 23 6.
15. Chan E, Rappaport L, Kemper K. Complementary and alternative therapies in childhood attention and hyperactivity problems. J. Dev. Behav. Pediatr. 2002 24 (1 4 8.
16. Spencer T, Biederman J, Wilens T, Faraone S. Overview and neurobiology of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 2002 63 (Suppl. 12 3 9.
17. Efron D, Jarman F, Barker M. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind crossover trial. Pediatrics 1997 100 (6 E6.
18. Arnold LE. Methylphenidate versus dexamphetamine: Comparative review. J. Atten. Disord. 2000 4 (1 200 11.
19. Greenhill L, Abikoff H, Arnold E, Cantwell D. Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. J. Am. Acad. Child Adolesc. Psychiatry 1996 35 (10 1304 13.
20. MTA Co-operative Group. National Institute of Mental Health Multimodal study of ADHD follow-up: 24 month outcomes of treatment strategies for attention deficit/hyperactivity disorder. Pediatrics 2004 113 (4 754 61.
21. Abikoff H, Hechtman L, Klein R et al. Symptomatic improvement in children with long term methylphenidate and multimodal psychosocial treatment. J. Am. Acad. Child Adolesc. Psychiatry 2004 43 (7 802 11.
22. Barkley R. Psychosocial treatments for attention deficit/hyperactivity disorder in children. J. Clin. Psychiatry 2002 63 (Suppl 36 43
23. Gross-Tsur V. Use of complementary medicine in children with attention deficit hyperactivity disorder. Pediatr. Neurol. 2003 29 (1 53 5.
24. Bateman B, Warner J, Hutchinson E et al. The effects of a double-blind placebo-controlled artificial food colourings and benzoate preservative challenge on hyperactivity in a general population study of preschool children. Arch. Dis. Child. 2004 89 : 506 11.
25. Wolraich M, Wilson D, While J. The effect of sugar on behaviour or cognition in children: A meta-analysis. JAMA 1996 275 (10 756 7.
26. Stevens L, Zentali S, Deck J et al. Essential fatty acid metabolism in boys with attention deficit hyperactivity disorder. Am. J. Clin. Nutr. 1995 62 : 761 8.
27. Bekaroglu M, Aslan Y, Gedik Y et al. Relationship between serum free fatty acids and zinc and attention deficit hyperactivity disorder: A research note. J. Child Psychol. Psychiatry Allied Disciplines 1996 37 (2 225 7.
28. Stevens L, Zhang W, Peck L et al. EFA supplementation in children with inattention, hyperactivity and other disruptive behaviours. Lipids 2003 38 (10 1007 21.
29. Voigt R, Llorente A, Jensen C, Fraley J, Berretta M, Heird W. A randomised, double blind, placebo controlled trial of docosahexaenoic acid supplementation in children with attention deficit hyperactivity disorder. J. Pediatr. 2001 139 (2 189 96.
30. Hirayama S, Hamazaki T, Trasawa K. Effect of DHA containing food administration on symptoms of ADHD A placebo-controlled, double blind study. Eur. J. Clin. Nutr. 2004 58 (3 467 73.
31. Richardson A, Montgomery P. The Oxford-Durham study: A randomised controlled trial of dietary supplementation with fatty acids in children with Developmental Coordination Disorder. Pediatrics 2005 115 (5 1360 66.
32. Bukstein OG. Satisfaction with treatment for attention deficit/hyperactivity disorder. Am. J. Manag. Care 2004 10 : S107 16.
33. Kaufman K. Dissertation Abstracts International: Science and Engineering, Vol 64 (7-b). US : UNIB Microfilms International, 2004.
34. Jackson J, Chamberlain J, Kroenkek K. Predictors of patient satisfaction. Soc. Sci. Med. 2001 52 : 609 20.
35. Mason K, Olm-Galla A, Bacon D. Experience of consumers' and providers' perspective on service quality. Community Ment. Health J. 2004 40 : 33 46.
36. Hazell PL, Lewin T, McDowell M, Walton J. Factors associated with medium-term response to psycho stimulant medication. J. Paediatr. Child Health 1999 35 (3 264 48.
37. Lambert W, Salzer M, Bickman L. Clinical outcome, consumer satisfaction and ad hoc ratings of improvement in children's mental health. J. Consult. Clin. Psychol. 1998 26 : 87 98.
38. Quitkin FM. Placebos, drug effects and study design: A clinician's guide. Am. J. Psychiatry 1999 156 (6 829 36.